LSBCF (LakeShore Biopharma Co) Inventories, Work In Process: $8.02 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Inventories, Work In Process?

LakeShore Biopharma Co LSBCF Inventories, Work In Process is $8.02 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. LakeShore Biopharma Co's work in process for the quarter that ended in Mar. 2025 was $8.02 Mil.


LakeShore Biopharma Co Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Inventories, Work In Process Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Inventories, Work In Process
3.60 6.43 8.89 6.82 8.02

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only 8.89 0.00 6.82 0.00 8.02

LakeShore Biopharma Co Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of $8.02 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Inventories, Work In Process of $8.02 Mil as of Mar. 2025. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Inventories, Work In Process too high?
LakeShore Biopharma Co's current Inventories, Work In Process is $8.02 Mil.
How does LakeShore Biopharma Co's Inventories, Work In Process compare to ACUT and PPCB?
LakeShore Biopharma Co's Inventories, Work In Process of $8.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Biotechnology company?
A good Inventories, Work In Process depends on the Biotechnology industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Inventories, Work In Process is $8.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Inventories, Work In Process of $8.02 Mil. The current Inventories, Work In Process is $8.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Inventories, Work In Process is $8.02 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.